Alex Goldberg

Amgen Inc. (NASDAQ:AMGN) and Linear Technology Corporation (NASDAQ:LLTC) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/03/2014 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Amgen Inc. (NASDAQ:AMGN) and Linear Technology Corporation (NASDAQ:LLTC).

Amgen Inc. (NASDAQ:AMGN) a biotechnology medicines company that engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada is currently down (-0.98%) on 2,265,347 shares traded after Amgen Announced Positive Top-Line Results From Phase 3 RUTHERFORD-2 Trial Of Evolocumab In Patients With Heterozygous Familial Hypercholesterolemia. Amgen Inc. (NASDAQ:AMGN) is currently down (-5.11%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Amgen Inc. (NASDAQ:AMGN)

Linear Technology Corporation (NASDAQ:LLTC) a company that together with its subsidiaries, designs, manufactures, and markets a line of analog integrated circuits worldwide is currently down (-0.16%) on 2,041,853 shares traded. Linear Technology Corporation (NASDAQ:LLTC) is currently down (-4.96%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Linear Technology Corporation (NASDAQ:LLTC)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com